Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$903,020
-$14,549 QoQ
Shares Held
5,762
-4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#655
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dickmeyer Boyce Financial Management, Inc. holds $15,255,912 across 9 Drug Manufacturers - General names. NVS ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,392 | $5,432,926 | |
| 2 | ABBV |
AbbVie Inc.
|
15,383 | $3,870,978 | |
| 3 | LLY |
ELI LILLY & Co
|
1,132 | $1,357,754 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,129 | $1,301,576 | |
| 5 | AMGN |
Amgen Inc
|
2,893 | $1,047,613 | |
| 6 | NVS |
Novartis AG
This page
|
5,762 | $903,020 | |
| 7 | PFE |
Pfizer Inc
|
24,471 | $589,261 | |
| 8 | NVO |
Novo Nordisk A S
|
11,471 | $549,919 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $903,020 | 5,762 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $917,569 | 6,007 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||